SEC Company Response from GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515) (GTHP) — Jan 23, 2023
GUIDED THERAPEUTICS INC (GTHP) (CIK 0000924515)
Date: Jan. 23, 2023 · CIK: 0000924515 · Accession: 0001477932-23-000494
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269229
Letter
VIA EDGAR Division of Corporation Finance Office of Industrial Applications and Services Guided Therapeutics, Inc. Registration Statement on Form S-1 Filed January 13, 2023 File No. 333-269229
Dear Mr. Richie:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Guided Therapeutics, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. ET on Wednesday, January 25, 2023, or as soon as thereafter practicable.
Very truly yours,
/s/ Gene S. Cartwright
Show Raw Text
CORRESP
1
filename1.htm
gthp_corresp.htmGuided Therapeutics, Inc.
15835 Peachtree Corners East, Suite B
Norcross, Georgia 30092
January 23, 2023
VIA EDGAR
Benjamin Richie
Division of Corporation Finance
Office of Industrial Applications and Services
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549-4561
Re:
Guided Therapeutics, Inc.
Registration Statement on Form S-1
Filed January 13, 2023
File No. 333-269229
Dear Mr. Richie:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Guided Therapeutics, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. ET on Wednesday, January 25, 2023, or as soon as thereafter practicable.
Very truly yours,
/s/ Gene S. Cartwright
Gene S. Cartwright
Chief Executive Officer
cc:
Ellenoff Grossman & Schole LLP